A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Recruiting · NCT05867420 · Registry updated 2026-01-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-01-27 | NCT05867420 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AskGene Pharma, Inc. | 3 |
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 9 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Irving Medical Center | New York | United States | 234 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 19 |
| Peking University Cancer Hospital | Beijing | China | 1 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |